Patent ID: 11972844
Assignee: ASTRAZENECA UK LIMITED
Field: Medical technology (Instruments)
Classification: CPC G | IPC G

Claim 16:
17. The computer system of claim 1, wherein the method further comprises:
c) responsive to receiving a re-order request from the subject for the statin pharmaceutical composition, performing a procedure comprising:
(i) conducting a second survey thereby obtaining a second plurality of survey results from the subject, wherein the second plurality of survey results comprises:
whether the subject has experienced a muscle irregularity since taking the statin pharmaceutical composition,
whether the subject is pregnant,
whether the subject is taking a medication that interacts with the statin pharmaceutical composition, and
whether the subject had an atherosclerotic cardiovascular event or a heart procedure since last ordering the statin pharmaceutical composition;

(ii) running all or a portion of the second plurality of survey results against a third plurality of filters, wherein, when a respective filter in the third plurality of filters is fired, the subject is provided with a warning corresponding to the respective filter, and wherein the third plurality of filters comprises:
the pregnancy filter,
a muscle irregularity filter,
a second drug interaction filter, and
the atherosclerotic cardiovascular event filter;

(iii) obtaining, when the re-fulfillment process is not terminated, acknowledgment from the subject for each warning issued to the subject by any filter in the third plurality of filters, and
(iv) proceeding with the re-fulfillment process when (i) the re-fulfillment process is not already terminated by the firing of a filter in the third plurality of filters and (ii) the subject has acknowledged each warning associated with each filter in the third plurality of filters that was fired and that is associated with a warning, wherein the re-fulfillment process further comprises:
storing an indication in a subject profile of a re-order for the statin pharmaceutical composition,
communicating an over the counter drug facts label for the statin pharmaceutical composition to the subject, and
authorizing, upon confirmation from the subject that the over the counter drug facts label has been received and read, a re-order provision of the statin pharmaceutical composition to the subject, wherein the re-order provision includes a destination of the subject,

wherein the statin pharmaceutical composition is administered to the subject after the authorizing to lower cholesterol.